246 related articles for article (PubMed ID: 28890542)
1. Multi-epitope vaccines: a promising strategy against tumors and viral infections.
Zhang L
Cell Mol Immunol; 2018 Feb; 15(2):182-184. PubMed ID: 28890542
[No Abstract] [Full Text] [Related]
2. Multi-epitope DNA vaccines.
Suhrbier A
Immunol Cell Biol; 1997 Aug; 75(4):402-8. PubMed ID: 9315485
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate-based vaccines: challenges and opportunities.
Huang YL; Wu CY
Expert Rev Vaccines; 2010 Nov; 9(11):1257-74. PubMed ID: 21087106
[TBL] [Abstract][Full Text] [Related]
4. In silico analyses of Wilms׳ tumor protein to designing a novel multi-epitope DNA vaccine against cancer.
Khalili S; Rahbar MR; Dezfulian MH; Jahangiri A
J Theor Biol; 2015 Aug; 379():66-78. PubMed ID: 25936349
[TBL] [Abstract][Full Text] [Related]
5. Neoepitope Vaccines Next Immunotherapy Frontier.
Cancer Discov; 2016 Feb; 6(2):112. PubMed ID: 26712929
[TBL] [Abstract][Full Text] [Related]
6. Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
DeLeo AB; Whiteside TL
Expert Rev Vaccines; 2008 Sep; 7(7):1031-40. PubMed ID: 18767952
[TBL] [Abstract][Full Text] [Related]
7. A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.
Berzofsky JA
Vaccine; 2012 Jun; 30(29):4323-7. PubMed ID: 22115635
[TBL] [Abstract][Full Text] [Related]
8. A focus on vaccination strategies.
Woodland DL
Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
[No Abstract] [Full Text] [Related]
9. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors.
Arens R
Adv Immunol; 2012; 114():217-43. PubMed ID: 22449784
[TBL] [Abstract][Full Text] [Related]
10. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in cancer immunotherapy with an emphasis on vaccines.
Cavallo F; Forni G
Expert Rev Vaccines; 2009 Jan; 8(1):25-8. PubMed ID: 19093768
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in epitope design for immunotherapy of cancer.
Chiarella P; Massi E; De Robertis M; Fazio VM; Signori E
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):227-40. PubMed ID: 19522699
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a multi-epitope subunit vaccine against avian leukosis virus subgroup J in chickens.
Xu Q; Ma X; Wang F; Li H; Zhao X
Virus Res; 2015 Dec; 210():62-8. PubMed ID: 26196055
[TBL] [Abstract][Full Text] [Related]
14. Getting peptide vaccines to work: just a matter of quality control?
Celis E
J Clin Invest; 2002 Dec; 110(12):1765-8. PubMed ID: 12488425
[No Abstract] [Full Text] [Related]
15. Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.
Atherton MJ; Stephenson KB; Nikota JK; Hu QN; Nguyen A; Wan Y; Lichty BD
Vaccine; 2018 Apr; 36(16):2181-2192. PubMed ID: 29544689
[TBL] [Abstract][Full Text] [Related]
16. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
Gross DA; Graff-Dubois S; Opolon P; Cornet S; Alves P; Bennaceur-Griscelli A; Faure O; Guillaume P; Firat H; Chouaib S; Lemonnier FA; Davoust J; Miconnet I; Vonderheide RH; Kosmatopoulos K
J Clin Invest; 2004 Feb; 113(3):425-33. PubMed ID: 14755339
[TBL] [Abstract][Full Text] [Related]
17. Composite peptide-based vaccines for cancer immunotherapy (Review).
Yang J; Zhang Q; Li K; Yin H; Zheng JN
Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
[TBL] [Abstract][Full Text] [Related]
18. Letter from the Editor.
Ellis R
Hum Vaccin Immunother; 2015; 11(10):2333. PubMed ID: 26376012
[No Abstract] [Full Text] [Related]
19. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
Berumen J; Villegas N
Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
[TBL] [Abstract][Full Text] [Related]
20. [Epitope peptide vaccine with oncoantigen for cancer and its biomarker].
Hazama S; Maeda K; Oka M
Nihon Rinsho; 2012 Dec; 70(12):2189-93. PubMed ID: 23259395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
